Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Revenue

Rhythm Biosciences had revenue of 1.62M AUD in the half year ending December 31, 2025, a decrease of -4.02%. This brings the company's revenue in the last twelve months to 1.65M, down -47.96% year-over-year. In the fiscal year ending June 30, 2025, Rhythm Biosciences had annual revenue of 3.19M with 88.85% growth.

• Revenue (ttm): 1.65M
• Revenue Growth: -47.96%
• P/S Ratio: 44.71
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 73.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	3.19M	1.50M	88.85%
Jun 30, 2024	1.69M	-1.41M	-45.41%
Jun 30, 2023	3.10M	668.44K	27.54%
Jun 30, 2022	2.43M	1.32M	118.98%
Jun 30, 2021	1.11M	1.01M	1,008.51%